Skip to main content

Advertisement

Open Peer Review Reports for: Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
11 Mar 2019 Submitted Original manuscript
25 Apr 2019 Reviewed Reviewer Report - Adam Brufsky
5 Jul 2019 Reviewed Reviewer Report - Reviewer 2
9 Aug 2019 Author responded Author comments - Sabine Schmid
Resubmission - Version 2
9 Aug 2019 Submitted Manuscript version 2
15 Aug 2019 Reviewed Reviewer Report - Adam Brufsky
26 Aug 2019 Author responded Author comments - Sabine Schmid
Resubmission - Version 3
26 Aug 2019 Submitted Manuscript version 3
27 Aug 2019 Author responded Author comments - Sabine Schmid
Resubmission - Version 4
27 Aug 2019 Submitted Manuscript version 4
Publishing
29 Aug 2019 Editorially accepted
10 Sep 2019 Article published 10.1186/s12885-019-6105-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement